Psoriasis Active Not Recruiting Phase 3 Trials for Adalimumab (DB00051)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02207244A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and RetreatmentTreatment
NCT02207231A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisTreatment
NCT02762955Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque PsoriasisTreatment